|Founder||Dr Eddy Agbo|
Number of locations
|Nigeria, USA (Maryland)|
Editor: Tamia Adolph
Fyodor Biotechnologies is a biotech startup established by Dr Eddy Agbo that delivers innovative technological solutions for health problems globally. Fyodor’s flagship product is the Urine Malaria Test (UMT), which is the first and only non-blood test that is able to diagnose whether a fever is malaria-related or not, in 25 minutes or less.
This innovation has taken malaria testing to an inexpensive, consumer-based model which has sold half a million tests in Nigeria in 2019.
Fyodor (which means “Divine Gift”) was founded in 2008 by Nigerian entrepreneur Dr Eddy Agbo. As a postdoctoral fellow in infectious disease at John Hopkins University, Dr Eddy Agbo was inspired to create a testing service that is commercially viable and affordable.  The UMT underwent clinical trials led by The University of Lagos, John Hopkins University, Duke University, and Nigerian health groups and was eventually verified as an accurate blood test. After the clinical trials in 2013, the UMT was commercialised in 2019 in Nigeria.
The UMT was conceptualised in order to create easy access to malaria testing for consumers, similar to a pregnancy test or blood sugar test. Fyodor’s UMT is a urine test where patients simply urinate on a stick, and wait 25 minutes or less in order to identify whether they have malaria or not. The test does not require health care professionals or expensive medical equipment. It is an easy-to-use, at-home urine test. The UMT costs $2 per product, as an introductory price.
Dr Agbo moved to Maryland, USA in order to work as a senior researcher at John Hopkins University. It was during his time in the USA that he conceptualised Fyodor Biotechnologies.
In 2011, Fyodor Biotechnologies was granted a Small Business Innovation Research (SBIR) Phase 1 grant worth $150,000 by the National Science Foundation.In 2012, the company received a SBIR Phase 2 grant worth $476,000 by the National Science Foundation.
Awards and Recognition
The UMT won the inaugural 2015 Health Innovation Challenge Awards in Nigeria.
In 2016, the UMT was chosen for the Special Prize for Social Impact at the Innovation Prize for Africa from the African Innovation Foundation. Fyodor Biotechnologies was awarded the 10th edition Universal Biotech Innovation prize in 2018 for the UMT product under the category “Medtech”.Fyodor Biotechnologies participated in the Africa 2018 Investment Forum in Sharm el Sheik, Egypt.
- Biotechnologies. Retrieved 8 February, 2020.
- Creating Prosperity: Fyodor Biotechnologies. Retrieved 8 February, 2020.
- Profile Previews. Retrieved 11 February, 2020.
- Innovators Creating Prosperity: Fyodor Biotechnologies. Retrieved 8 February, 2020.
- Biotechnologies – Democratizing the Diagnosis of Malaria. Retrieved 11 February, 2020.
- Introducing the First Non-blood Malaria Test. Retrieved 11 February, 2020.
- Fyodor Biotechnologies Website. Retrieved 8 February, 2020.
- Disrupting Malaria: How Fyodor Biotechnologies is Changing the Diagnostics Game. Retrieved 11 February, 2020.
- Divine Gift. Retrieved 22 February, 2020.
- Fyodor Biotechnologies, Inc. Awarded a Fyodor Biotechnologies, Inc. National Science Foundation Grant. Retrieved 11 February, 2020.
- Fyodor Biotechnologies, Inc. Awarded Phase 2 SBIR Grant to Develop a Broad Urine-Based Diagnostic Test for Malaria. Retrieved 11 February, 2020.
- Nigeria-Made Rapid Urine Test for Malaria Wins Health Innovation Awards. Retrieved 11 February, 2020.
- IPA 2016 “Made in Africa” – June 22-23 Gaborone, Botswana. Retrieved 11 February, 2020.
- Discover the Winners of the 10th Edition of the Innovation Prize. Retrieved 11 February, 2020.
- Fyodor Biotechnologies News. Retrieved 14 February, 2020.